121 related articles for article (PubMed ID: 30295284)
1. [A Preliminary Study on the Expression of CD160 on NK Cells and Its Mechanism of Mediating NK Killing Effect].
Wang ZH; Liu HH; Ma N; Wang LH; Liu W; Tang B; Qiu ZX; Cen XN; Ren HY; Dong YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1559-1564. PubMed ID: 30295284
[TBL] [Abstract][Full Text] [Related]
2. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity.
Giustiniani J; Marie-Cardine A; Bensussan A
J Immunol; 2007 Feb; 178(3):1293-300. PubMed ID: 17237375
[TBL] [Abstract][Full Text] [Related]
3. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
Le Bouteiller P; Barakonyi A; Giustiniani J; Lenfant F; Marie-Cardine A; Aguerre-Girr M; Rabot M; Hilgert I; Mami-Chouaib F; Tabiasco J; Boumsell L; Bensussan A
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16963-8. PubMed ID: 12486241
[TBL] [Abstract][Full Text] [Related]
4. Increased CD160 expression on circulating natural killer cells in atherogenesis.
Zuo J; Shan Z; Zhou L; Yu J; Liu X; Gao Y
J Transl Med; 2015 Jun; 13():188. PubMed ID: 26071079
[TBL] [Abstract][Full Text] [Related]
5. [Expression of CD160 in natural killer (NK) cells from patients with active tuberculosis and its relationship with cell functions].
Yang B; Zhai F; An H; Cao Z; Liu Y; Wang R; Cheng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Oct; 38(10):918-924. PubMed ID: 36163624
[TBL] [Abstract][Full Text] [Related]
6. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
7. CD160: a unique activating NK cell receptor.
Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
[TBL] [Abstract][Full Text] [Related]
8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
9. CD160 receptor in CLL: Current state and future avenues.
Oumeslakht L; Aziz AI; Bensussan A; Ben Mkaddem S
Front Immunol; 2022; 13():1028013. PubMed ID: 36420268
[TBL] [Abstract][Full Text] [Related]
10. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria.
Giustiniani J; Alaoui SS; Marie-Cardine A; Bernard J; Olive D; Bos C; Razafindratsita A; Petropoulou A; de Latour RP; Le Bouteiller P; Bagot M; Socié G; Bensussan A
Curr Mol Med; 2012 Feb; 12(2):188-98. PubMed ID: 22172098
[TBL] [Abstract][Full Text] [Related]
11. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
[TBL] [Abstract][Full Text] [Related]
12. Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.
Scheffges C; Devy J; Giustiniani J; Francois S; Cartier L; Merrouche Y; Foussat A; Potteaux S; Bensussan A; Marie-Cardine A
Breast Cancer Res; 2024 Feb; 26(1):28. PubMed ID: 38360636
[TBL] [Abstract][Full Text] [Related]
13. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
[TBL] [Abstract][Full Text] [Related]
14. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.
Del Rio ML; Bravo Moral AM; Fernandez-Renedo C; Buhler L; Perez-Simon JA; Chaloin O; Alvarez Nogal R; Fernandez-Caso M; Rodriguez-Barbosa JI
Transl Res; 2017 Mar; 181():83-95.e3. PubMed ID: 27702550
[TBL] [Abstract][Full Text] [Related]
16. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HLA class I molecules and MHC class I chain-related molecules A/B in K562 and K562/AO2 cell lines and their effects on cytotoxicity of NK cells].
Mei JZ; Niu XQ; Guo KY; Zhou J; Wei HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):288-91. PubMed ID: 17493333
[TBL] [Abstract][Full Text] [Related]
19. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of peripheral CD160+ lymphocytes during the course of healthy human pregnancy.
Barakonyi A; Weisdorn R; Miko E; Varga P; Bodis J; Szekeres-Bartho J; Szereday L
Am J Reprod Immunol; 2011 Aug; 66(2):137-42. PubMed ID: 21276121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
